This work was supported by Schering-Plough and Pfizer, Inc. Editorial services were provided by Complete Healthcare Communications, Inc., and funded by Schering-Plough. RSM has received research funding from Wyeth, GlaxoSmithKline, Merck, Servier, and AstraZeneca; and has served as a consultant or speaker for AstraZeneca, Eli Lilly & Co., Janssen-Ortho, Schering-Plough, Wyeth, Lundbeck, GlaxoSmithKline, Oryx, Biovail, Pfizer, Prestwick, and Shire. MC, JZ, and JP are employees of Schering-Plough. LA and TAM were employed at Pfizer Global R&D at the time the study was conducted.
Asenapine versus olanzapine in acute mania: a double-blind extension study
Article first published online: 14 OCT 2009
© 2009 The Authors. Journal compilation © 2009 John Wiley & Sons A/S
Volume 11, Issue 8, pages 815–826, December 2009
How to Cite
McIntyre, R. S., Cohen, M., Zhao, J., Alphs, L., Macek, T. A. and Panagides, J. (2009), Asenapine versus olanzapine in acute mania: a double-blind extension study. Bipolar Disorders, 11: 815–826. doi: 10.1111/j.1399-5618.2009.00749.x
- Issue published online: 16 NOV 2009
- Article first published online: 14 OCT 2009
- Received 23 December 2008, revised and accepted for publication 5 July 2009
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.